Industry in brief | Dermapharm, Novartis, Stada

2 April 2020 - Deborah Wilkes

Archived

Dermapharm has reported its financial results for 2019, Novartis and Aurobindo have terminated a transaction, and Stada has made a people appointment in Portugal.

Click tags below for more information on topics:

Dermapharm Novartis Aurobindo Stada

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: